Cargando…
Immune response in peripheral axons delays disease progression in SOD1(G93A) mice
BACKGROUND: Increasing evidence suggests that the immune system has a beneficial role in the progression of amyotrophic lateral sclerosis (ALS) although the mechanism remains unclear. Recently, we demonstrated that motor neurons (MNs) of C57SOD1(G93A) mice with slow disease progression activate mole...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055725/ https://www.ncbi.nlm.nih.gov/pubmed/27717377 http://dx.doi.org/10.1186/s12974-016-0732-2 |
_version_ | 1782458804329250816 |
---|---|
author | Nardo, Giovanni Trolese, Maria Chiara de Vito, Giuseppe Cecchi, Roberta Riva, Nilo Dina, Giorgia Heath, Paul R. Quattrini, Angelo Shaw, Pamela J. Piazza, Vincenzo Bendotti, Caterina |
author_facet | Nardo, Giovanni Trolese, Maria Chiara de Vito, Giuseppe Cecchi, Roberta Riva, Nilo Dina, Giorgia Heath, Paul R. Quattrini, Angelo Shaw, Pamela J. Piazza, Vincenzo Bendotti, Caterina |
author_sort | Nardo, Giovanni |
collection | PubMed |
description | BACKGROUND: Increasing evidence suggests that the immune system has a beneficial role in the progression of amyotrophic lateral sclerosis (ALS) although the mechanism remains unclear. Recently, we demonstrated that motor neurons (MNs) of C57SOD1(G93A) mice with slow disease progression activate molecules classically involved in the cross-talk with the immune system. This happens a lot less in 129SvSOD1(G93A) mice which, while expressing the same amount of transgene, had faster disease progression and earlier axonal damage. The present study investigated whether and how the immune response is involved in the preservation of motor axons in the mouse model of familial ALS with a more benign disease course. METHODS: First, the extent of axonal damage, Schwann cell proliferation, and neuromuscular junction (NMJ) denervation were compared between the two ALS mouse models at the disease onset. Then, we compared the expression levels of different immune molecules, the morphology of myelin sheaths, and the presence of blood-derived immune cell infiltrates in the sciatic nerve of the two SOD1G93A mouse strains using immunohistochemical, immunoblot, quantitative reverse transcription PCR, and rotating-polarization Coherent Anti-Stokes Raman Scattering techniques. RESULTS: Muscle denervation, axonal dysregulation, and myelin disruption together with reduced Schwann cell proliferation are prominent in 129SvSOD1(G93A) compared to C57SOD1(G93A) mice at the disease onset, and this correlates with a faster disease progression in the first strain. On the contrary, a striking increase of immune molecules such as CCL2, MHCI, and C3 was seen in sciatic nerves of slow progressor C57SOD1(G93A) mice and this was accompanied by heavy infiltration of CD8(+) T lymphocytes and macrophages. These phenomena were not detectable in the peripheral nervous system of fast-progressing mice. CONCLUSIONS: These data show for the first time that damaged MNs in SOD1-related ALS actively recruit immune cells in the peripheral nervous system to delay muscle denervation and prolong the lifespan. On the contrary, the lack of this response has a negative impact on the disease course. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12974-016-0732-2) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5055725 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-50557252016-10-19 Immune response in peripheral axons delays disease progression in SOD1(G93A) mice Nardo, Giovanni Trolese, Maria Chiara de Vito, Giuseppe Cecchi, Roberta Riva, Nilo Dina, Giorgia Heath, Paul R. Quattrini, Angelo Shaw, Pamela J. Piazza, Vincenzo Bendotti, Caterina J Neuroinflammation Short Report BACKGROUND: Increasing evidence suggests that the immune system has a beneficial role in the progression of amyotrophic lateral sclerosis (ALS) although the mechanism remains unclear. Recently, we demonstrated that motor neurons (MNs) of C57SOD1(G93A) mice with slow disease progression activate molecules classically involved in the cross-talk with the immune system. This happens a lot less in 129SvSOD1(G93A) mice which, while expressing the same amount of transgene, had faster disease progression and earlier axonal damage. The present study investigated whether and how the immune response is involved in the preservation of motor axons in the mouse model of familial ALS with a more benign disease course. METHODS: First, the extent of axonal damage, Schwann cell proliferation, and neuromuscular junction (NMJ) denervation were compared between the two ALS mouse models at the disease onset. Then, we compared the expression levels of different immune molecules, the morphology of myelin sheaths, and the presence of blood-derived immune cell infiltrates in the sciatic nerve of the two SOD1G93A mouse strains using immunohistochemical, immunoblot, quantitative reverse transcription PCR, and rotating-polarization Coherent Anti-Stokes Raman Scattering techniques. RESULTS: Muscle denervation, axonal dysregulation, and myelin disruption together with reduced Schwann cell proliferation are prominent in 129SvSOD1(G93A) compared to C57SOD1(G93A) mice at the disease onset, and this correlates with a faster disease progression in the first strain. On the contrary, a striking increase of immune molecules such as CCL2, MHCI, and C3 was seen in sciatic nerves of slow progressor C57SOD1(G93A) mice and this was accompanied by heavy infiltration of CD8(+) T lymphocytes and macrophages. These phenomena were not detectable in the peripheral nervous system of fast-progressing mice. CONCLUSIONS: These data show for the first time that damaged MNs in SOD1-related ALS actively recruit immune cells in the peripheral nervous system to delay muscle denervation and prolong the lifespan. On the contrary, the lack of this response has a negative impact on the disease course. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12974-016-0732-2) contains supplementary material, which is available to authorized users. BioMed Central 2016-10-07 /pmc/articles/PMC5055725/ /pubmed/27717377 http://dx.doi.org/10.1186/s12974-016-0732-2 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Short Report Nardo, Giovanni Trolese, Maria Chiara de Vito, Giuseppe Cecchi, Roberta Riva, Nilo Dina, Giorgia Heath, Paul R. Quattrini, Angelo Shaw, Pamela J. Piazza, Vincenzo Bendotti, Caterina Immune response in peripheral axons delays disease progression in SOD1(G93A) mice |
title | Immune response in peripheral axons delays disease progression in SOD1(G93A) mice |
title_full | Immune response in peripheral axons delays disease progression in SOD1(G93A) mice |
title_fullStr | Immune response in peripheral axons delays disease progression in SOD1(G93A) mice |
title_full_unstemmed | Immune response in peripheral axons delays disease progression in SOD1(G93A) mice |
title_short | Immune response in peripheral axons delays disease progression in SOD1(G93A) mice |
title_sort | immune response in peripheral axons delays disease progression in sod1(g93a) mice |
topic | Short Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055725/ https://www.ncbi.nlm.nih.gov/pubmed/27717377 http://dx.doi.org/10.1186/s12974-016-0732-2 |
work_keys_str_mv | AT nardogiovanni immuneresponseinperipheralaxonsdelaysdiseaseprogressioninsod1g93amice AT trolesemariachiara immuneresponseinperipheralaxonsdelaysdiseaseprogressioninsod1g93amice AT devitogiuseppe immuneresponseinperipheralaxonsdelaysdiseaseprogressioninsod1g93amice AT cecchiroberta immuneresponseinperipheralaxonsdelaysdiseaseprogressioninsod1g93amice AT rivanilo immuneresponseinperipheralaxonsdelaysdiseaseprogressioninsod1g93amice AT dinagiorgia immuneresponseinperipheralaxonsdelaysdiseaseprogressioninsod1g93amice AT heathpaulr immuneresponseinperipheralaxonsdelaysdiseaseprogressioninsod1g93amice AT quattriniangelo immuneresponseinperipheralaxonsdelaysdiseaseprogressioninsod1g93amice AT shawpamelaj immuneresponseinperipheralaxonsdelaysdiseaseprogressioninsod1g93amice AT piazzavincenzo immuneresponseinperipheralaxonsdelaysdiseaseprogressioninsod1g93amice AT bendotticaterina immuneresponseinperipheralaxonsdelaysdiseaseprogressioninsod1g93amice |